Tacrolimus- VINGRAF Capsules

Listing ID #2189143

Prograf [Tacrolimus]
Strength Volume Type
Prograf 0.5mg 50 Capsule
Prograf 1 mg 50 Capsule
Prophylaxis of transplant rejection in liver, kidney or heart allograft recipients. Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products. Prograf has been used with or without antibody induction in transplantation. The dose recommendations for lung, pancreas and intestinal transplantation are based on limited prospective clinical trial data. In lung-transplanted patients Prograf has been used at an initial oral dose of 0.10 - 0.15 mgkgday, in pancreas-transplanted patients at an initial oral dose of 0.2 mgkgday and in intestinal transplantation at an initial oral dose of 0.3 mgkgday.